Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Point Biopharma Global Inc (NQ: PNT )

13.68 -0.04 (-0.29%)
Streaming Delayed Price Updated: 12:17 PM EST, Dec 6, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Point Biopharma Global Inc

< Previous 1 2 3 4 Next >
5 Value Stocks To Watch In The Healthcare Sector
Via Benzinga
Amicus Therapeutics Stock Scores Relative Strength Rating Upgrade; Hits Key Benchmark
One key metric to look for in a stock is an 80-plus RS Rating. Amicus Therapeutics stock hit that mark, with a jump from 74 to 82 Friday. 
Via Investor's Business Daily
Why Shares of Point Biopharma Global Rose Monday
The company made a deal to help speed its clinical trials along. 
Via The Motley Fool
Arlo Technologies, Array Technologies, AirSculpt Technologies And Other Big Stocks Moving Higher On Friday
U.S. stocks traded slightly lower, with the Dow Jones dropping around 15 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
7 Biotech Stocks With Huge Return Potential for Long-Term Investors
Although a wildly speculative sector, the low-cost, high-potential biotech stocks to buy and hold may deliver the goods for gamblers. 
Via InvestorPlace
Earnings Preview: POINT Biopharma Global
Via Benzinga
Lantheus and POINT Biopharma Announce FDA Grants Fast Track Designation for ¹⁷⁷Lu-PNT2002 for the Treatment of Metastatic Castration Resistant Prostate Cancer
From Lantheus Holdings, Inc.; POINT Biopharma Global Inc.
Via GlobeNewswire
7 Thrilling Biotech Stocks for Aggressive Investors to Buy
Amid the noise of the global markets recently, these speculative biotech stocks to buy might trade with a mind of their own. 
Via InvestorPlace
Earnings Scheduled For March 24, 2023
Companies Reporting Before The Bell • Sunlands Technology (NYSE:STG) is likely to report earnings for its fourth quarter. • Caledonia Mining (AMEX:CMCL) is projected to report earnings for its fourth... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 30, 2022
Via Benzinga
Over $16 Million Bet On Energy Transfer? Check Out These 3 Stocks Insiders Are Buying
Although US stocks closed lower on Monday, there were a few notable insider trades. 
Via Benzinga
Analyst Ratings for POINT Biopharma Global
Over the past 3 months, 5 analysts have published their opinion on POINT Biopharma Global (NASDAQ:PNT) stock. These analysts are typically employed by large Wall Street banks and tasked with... 
Via Benzinga
Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From Yesterday
Gainers Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) shares surged 113.8% to settle at $20.10 on Monday. Indivior PLC agreed to acquire Opiant Pharmaceuticals for $20.00 per share in cash, plus... 
Via Benzinga
Dow Surges 150 Points; Crude Oil Falls Sharply
U.S. stocks traded mostly higher toward the end of trading, with the Dow Jones gaining around 150 points on Monday. 
Via Benzinga
Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 53 Stocks Moving In Monday's Mid-Day Session
Gainers Freight Technologies, Inc. (NASDAQ: FRGT) shares surged 137% to $0.4901 after analysts at Chardan Capital initiated coverage of the stock with a $2.25 price target. 
Via Benzinga
Lantheus-POINT Biopharma Ink Strategic Collaboration For Cancer Programs
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers 
Via Benzinga
Stocks Cool Off From Last Week's Rally
Stocks are starting the week off lower, unable to build off of last week's impressive rally. 
Via Talk Markets
Silver Rises Over 1%; Tyson Foods Posts Downbeat Earnings
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite dropping around 60 points on Monday. 
Via Benzinga
Hasbro, Ascendis Pharma, Coinbase Global And Some Other Big Stocks Moving Lower On Monday
U.S. stocks traded mixed, with the Nasdaq gaining more than 50 points on Monday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
US Stocks Mostly Lower; Nasdaq Drops Over 100 Points
U.S. stocks traded mostly lower this morning, with the Nasdaq Composite dropping more than 100 points on Monday. 
Via Benzinga
Lantheus and POINT Biopharma Announce Strategic Collaboration and Exclusive License Agreements for the Commercialization of PNT2002 & PNT2003
From Lantheus Holdings, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Benitec Biopharma (NASDAQ:BNTC) shares increased by 9.8% to $0.35 during Tuesday's after-market session. The company's market cap stands at $9.0 million. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 16, 2022
  
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2022
Upgrades 
Via Benzinga
Why Vintage Wine Estates Shares Tumbled 40%; Here Are 70 Biggest Movers From Yesterday
Gainers AMTD Digital Inc. (NYSE: HKD) shares jumped 311.8% to settle at $189.42 on Wednesday as the stock experienced a resurgence in momentum despite a lack of fundamental news. 
Via Benzinga
Nucor, Altimmune And Some Other Big Stocks Moving Lower On Wednesday
U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Wednesday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Why SciSparc Is Trading Higher By 68%, Here Are 48 Stocks Moving In Wednesday's Mid-Day Session
Gainers Akerna Corp. (NASDAQ: KERN) shares rose 81.2% to $0.2355 after gaining 8% on Tuesday. 
Via Benzinga
Why POINT Biopharma Shares Are Getting Hammered
POINT Biopharma Global Inc (NASDAQ: PNT) shares are trading lower by 11.41% to $9.01 Wednesday morning after the company priced a public offering of 13.9 million shares of common stock at $9 per share.... 
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.